Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
investing
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
startups
venture capital
2
×
acute myeloid leukemia
american society of clinical oncology
antisense oligonucleotide
applied therapeutics
benzodiazepines
biogen
biosimilars
blackstone group
blackstone life sciences
boston
boulder/denver blog main
boulder/denver top stories
breast cancer
cancer
cell therapy
christopher heery
cincor pharma
columbia university
cystic fibrosis
david goldstein
deals
depression
detroit blog main
detroit top stories
diabetic cardiomyopathy
drug prices
drugs
duchenne muscular dystrophy
What
drugs
2
×
ahead
aims
asco
backed
bio
branded
cause
ceo
choices
commissioner
consumers
costly
counterweight
elevatebio
epilepsy
fda
generic
genes
genetic
graft
links
marcio
medications
medicines
mutations
neuro
new
praxis
precision
research
rises
roundup
souza
stop
supposed
tenure
turn
Language
unset
Current search:
xconomy.com
×
drugs
×
" venture capital "
×
" new york top stories "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More